The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The promise of minocycline in neurology
Abstract
The capacity of minocycline to alleviate disease for several neurological disorders in animals is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of disease in stroke, multiple sclerosis, spinal-cord injury, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis is astounding. In this review, we describe the evidence for the efficacy of minocycline in several animal models of neurological disease, discuss the mechanisms by which minocycline affects a range of neurological diseases with diverse causes, and introduce the emerging investigation of minocycline in clinical neurology. The encouraging results of minocycline in experimental neurology bode well for its therapeutic use in human neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
Citations
Cites
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Research works printed but not linked: 1
- Giuliani, 2004, Synergistic activity of minocycline and glatiramer acetate in an animal model of multiple sclerosis, Mult Scler, 9, S76
Cited by
Sorted by citations
Items 201–300 of 523
Patriarca, A., Polticelli, F., Piro, M. C., Sinibaldi, F., Mei, G., Bari, M., Santucci, R., & Fiorucci, L. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.028 · Cited by 43
Immunotherapies in Huntington's disease and α-Synucleinopathies
Fatoba, O., Ohtake, Y., Itokazu, T., & Yamashita, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00337 · Cited by 45
Xing, C., Lee, S.-R., Kim, W. J., Wang, H., Yang, Y., Ning, M., Wang, X., & Lo, E. H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22076 · Cited by 43
Irani, D. N., & Prow, N. A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000263867.46070.e2 · Cited by 43
Liu, W.-T., Huang, C.-Y., Lu, I.-C., & Gean, P. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not073 · Cited by 43
Minocycline mitigates the effect of neonatal hypoxic insult on human brain organoids
Boisvert, E. M., Means, R. E., Michaud, M., Madri, J. A., & Katz, S. G. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1553-x · Cited by 45
Protective effects of minocycline on experimental spinal cord injury in rats
Aras, M., Altaş, M., Motor, S., Dokuyucu, R., Yılmaz, A., Özgiray, E., Seraslan, Y., & Yılmaz, N. (2015) · Injury · doi:10.1016/j.injury.2015.05.018 · Cited by 42
Hou, Y., Ryu, C. H., Park, K., Kim, S. M., Jeong, C., & Jeun, S. (2013) · Stem cell research & therapeutics · doi:10.1186/scrt228 · Cited by 44
Minocycline added to subcutaneous interferon β‐1a in multiple sclerosis: randomized RECYCLINE study
Sørensen, P. S., Sellebjerg, F. T., Lycke, J., Färkkilä, M. A., Créange, A., Lund, C., Schluep, M., Frederiksen, J. L., Stenager, E., Pfleger, C., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12953 · Cited by 42
Hsieh, C.-T., Lee, Y., Dai, X., Ojeda, N. B., Lee, H. J., Tien, L., & Fan, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102947 · Cited by 42
Arezoomandan, R., & Haghparast, A. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0209 · Cited by 41
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
Sisignano, M., Gribbon, P. M., & Geißlinger, G. (2022) · Drugs · doi:10.1007/s40265-022-01689-0 · Cited by 42
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation
D’Ambrosio, R., Eastman, C. L., Fattore, C., & Perucca, E. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.54 · Cited by 41
Minocycline Blocks Acute Bilirubin-Induced Neurological Dysfunction in Jaundiced Gunn Rats
Geiger, A. S., Rice, A. C., & Shapiro, S. M. (2007) · Neonatology · doi:10.1159/000103740 · Cited by 40
Multiple sclerosis – novel insights and new therapeutic strategies
Kieseier, B. C., Hemmer, B., & Hartung, H. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169735.60922.fb · Cited by 39
Expression Profiling of Genes Modulated by Minocycline in a Rat Model of Neuropathic Pain
Rojewska, E., Korostyński, M., Przewłocki, R., Przewłocka, B., & Mika, J. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-47 · Cited by 40
Hiraga, S.-I., Itokazu, T., Hoshiko, M., Takaya, H., Nishibe, M., & Yamashita, T. (2020) · JCI Insight · doi:10.1172/jci.insight.131801 · Cited by 40
The function of SUMOylation and its crucial roles in the development of neurological diseases
Chen, X., Zhang, Y., Wang, Q., Qin, Y., Yang, X., Xing, Z., Shen, Y., Wu, H., & Qi, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202002702r · Cited by 39
Liebigt, S., Schlegel, N., Oberland, J., Witte, O. W., Redecker, C., & Keiner, S. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.037 · Cited by 39
Use of minocycline in viral infections.
Dutta, K., & Basu, A. (2011) · PubMed Central · Cited by 39
Effects of minocycline on Na+ currents in rat dorsal root ganglion neurons
Kim, T. H., Kim, H. I., Kim, J., Park, M., & Song, J.-H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.038 · Cited by 38
Kumar, A., Rinwa, P., & Dhar, H. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0187-3 · Cited by 39
Experimental models of neuroprotection relevant to multiple sclerosis
Yong, V. W., Giuliani, F., Xue, M., Bar‐Or, A., & Metz, L. M. (2007) · Neurology · doi:10.1212/01.wnl.0000275230.20635.72 · Cited by 38
Hahn, J. N., Kaushik, D. K., Mishra, M. K., Wang, J., Silva, C. G., & Yong, V. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600436 · Cited by 37
Faissner, S., Mahjoub, Y., Mishra, M. K., Haupeltshofer, S., Hahn, J. N., Gold, R., Koch, M. W., Metz, L. M., Ben‐Hur, T., & Yong, V. W. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517728811 · Cited by 37
Recombinant Tissue Plasminogen Activator Enhances Microglial Cell Recruitment after Stroke in Mice
Lenglet, S., Montecucco, F., Dénes, Á., Coutts, G., Pinteaux, E., Mach, F., Schaller, K., Gasche, Y. G., & Copin, J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.9 · Cited by 36
CNS and peripheral immunity in cerebral ischemia: partition and interaction
Kim, E., & Cho, S. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113508 · Cited by 37
Lee, J., Lee, S.-B., Kim, D. W., Shin, N., Jeong, S.-J., Yang, C. H., & Son, C. (2021) · Science Advances · doi:10.1126/sciadv.abj3400 · Cited by 36
An emerging role of cGMP in the treatment of schizophrenia: A review
Shim, S. S., Shuman, M. D., & Duncan, E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.015 · Cited by 35
Revisiting Minocycline in Intracerebral Hemorrhage: Mechanisms and Clinical Translation
Zhang, R., Yong, V. W., & Xue, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844163 · Cited by 36
Pinkernelle, J., Fansa, H., Ebmeyer, U., & Keilhoff, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073422 · Cited by 37
Kato, T. A., Watabe, M., Tsuboi, S., Ishikawa, K., Hashiya, K., Monji, A., Utsumi, H., & Kanba, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040461 · Cited by 34
Tetracyclines cause cell stress-dependent ATF4 activation and mTOR inhibition
Brüning, A., Brem, G., Vogel, M., & Mylonas, I. G. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.11.012 · Cited by 35
Takeda, M., Kawaguchi, M., Kumatoriya, T., Horiuchi, T., Watanabe, K., Inoue, S., Konishi, N., & Furuya, H. (2011) · Spine · doi:10.1097/brs.0b013e3181ffda29 · Cited by 35
Inhibiting effect of minocycline on the regeneration of peripheral nerves
Keilhoff, G., Langnaese, K., Wolf, G. L., & Fansa, H. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20384 · Cited by 35
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials
Liu, M., Wang, Z., & Shang, H. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12269-5 · Cited by 36
Molecular Mechanisms of Cell Death
Lemasters, J. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00001-9 · Cited by 37
Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
Park, C., Kim, S., & Lee, C. (2020) · Immune Network · doi:10.4110/in.2020.20.e47 · Cited by 34
Keilhoff, G., Schild, L., & Fansa, H. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.028 · Cited by 34
Pérez‐Gómez, A., Carretero, M., Weber, N., Peterka, V., To, A., Titova, V., Solis, G. M., Osborn, O., & Petrascheck, M. (2018) · Nature Communications · doi:10.1038/s41467-018-07684-y · Cited by 35
Contribution of intraganglionic CGRP to migraine-like responses in male and female rats
Araya, E. I., Turnes, J. D. M., Barroso, A. R., & Chichorro, J. G. (2019) · Cephalalgia · doi:10.1177/0333102419896539 · Cited by 32
Haroon, M. F., Fatima, A., Schöler, S., Gieseler, A., Horn, T. F. W., Kirches, E., Wolf, G. L., & Kreutzmann, P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.021 · Cited by 33
Opdenakker, G., & Damme, J. V. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.11.005 · Cited by 33
Corsaro, A., Thellung, S., Chiovitti, K., Villa, V., Simi, A., Raggi, F., Paludi, D., Russo, C., Aceto, A., & Florio, T. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9015-3 · Cited by 33
Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening
Pandamooz, S., Nabiuni, M., Miyan, J. A., Ahmadiani, A., & Dargahi, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9403-z · Cited by 34
Kim, J. W., Hong, J. Y., & Bae, S. M. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.3.246 · Cited by 35
Anti-inflammatory and antiviral effects of minocycline in enterovirus 71 infections
Liao, Y.-T., Wang, S.-M., & Chen, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109271 · Cited by 32
Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death
Fernández-Gómez, F.-J., Gómez-Lázaro, M., Pastor, M. D., Calvo, S., Aguirre, N., Galindo, M. F., & Jordán, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.019 · Cited by 32
A new approach for the investigation of reperfusion-related brain injury
Maier, C. M., Hsieh, L. B., Crandall, T., Narasimhan, P., & Chan, P. H. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341366 · Cited by 32
Role of oxidative stress and caspase 3 in CD47‐mediated neuronal cell death
Xing, C., Lee, S.-R., Kim, W. J., Jin, G., Yang, Y., Ji, X., Wang, X., & Lo, E. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05777.x · Cited by 32
Zazula, R., Husain, M. I., Mohebbi, M., Walker, A. J., Chaudhry, I. B., Khoso, A. B., Ashton, M. M., Agustini, B., Husain, N., Deakin, J., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420965697 · Cited by 31
Emerging Therapies for Relapsing Multiple Sclerosis
Cohen, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.104 · Cited by 31
Toledo, M. A., Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112068 · Cited by 31
Carabelli, B., Delattre, A. M., Waltrick, A. P. F., Araújo, G., Suchecki, D., Machado, R. B., de Souza, L. E. R., Zanata, S. M., Zanoveli, J. M., & Ferraz, A. C. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112675 · Cited by 34
Ahmed, A., Misrani, A., Tabassum, S., Yang, L., & Long, C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.028 · Cited by 32
Zhang, Y., Metz, L., Yong, V. W., & Mitchell, J. R. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.014 · Cited by 30
Fragile X syndrome: from gene discovery to therapy
Heulens, I. (2010) · Frontiers in bioscience · doi:10.2741/3785 · Cited by 32
Chen, X., Hu, X., Zou, Y., Pi, R., Liu, M., Wang, T., Zheng, X., Liu, M., Lin, M., Liu, P., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.016 · Cited by 31
NANOCARRIERS FOR TARGETING IN INFLAMMATION
Shaji, J., & Lal, M. (2013) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 31
Cerebrospinal Fluid Biomarkers in Human Spinal Cord Injury from a Phase II Minocycline Trial
Casha, S., Rice, T. K., Stirling, D. P., Silva, C., Gnanapavan, S., Giovannoni, G., Hurlbert, R. J., & Yong, V. W. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5899 · Cited by 31
Tabassum, S., Misrani, A., Huo, Q., Ahmed, A., Long, C., & Yang, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03018-8 · Cited by 30
Role of microglia and toll-like receptor 4 in the pathophysiology of delirium
Jalleh, R. J., KOH, K. S. B., Choi, B., Liu, E., Maddison, J., & Hutchinson, M. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.013 · Cited by 31
Chemokines and Their Receptors in Intracerebral Hemorrhage
Yao, Y., & Tsirka, S. E. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0155-z · Cited by 32
Li, X., Tong, H., Xu, S., Zhou, G., Yang, T., Yin, S., Yang, S., Li, X., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111787 · Cited by 35
Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease
Kater, M. S. J., Huffels, C. F. M., Oshima, T., Renckens, N. S., Middeldorp, J., Boddeke, E., Smit, A. B., Eggen, B. J. L., Hol, E. M., & Verheijen, M. H. G. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.009 · Cited by 30
Wnęk, M., Ressel, L., Ricci, E., Rodriguez-Martinez, C., Guerrero, J. C. V., Ismail, Z., Smith, C., Kipar, A., Sodeik, B., Chinnery, P. F., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1597-2 · Cited by 29
Emerging chemotherapeutic strategies for Huntington’s disease
Ryu, H., & Ferrante, R. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.345 · Cited by 30
Oral Disease-Modifying Treatments for Multiple Sclerosis
Kieseier, B. C., & Wiendl, H. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00005 · Cited by 29
Maras, P. M., Hebda-Bauer, E. K., Hagenauer, M. H., Hilde, K. L., Blandino, P., Watson, S. J., & Akil, H. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01821-4 · Cited by 26
Cruz, S. L., Armenta-Reséndiz, M., Carranza‐Aguilar, C. J., & Galván, E. J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114980 · Cited by 28
Lee, G. J., Lim, J. J., & Hyun, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21224 · Cited by 28
Therapeutic Approaches to Multiple Sclerosis
Ulzheimer, J. C., Meuth, S. G., Bittner, S., Kleinschnitz, C., Kieseier, B. C., & Wiendl, H. (2010) · BioDrugs · doi:10.2165/11537160-000000000-00000 · Cited by 27
Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion
Hua, R., & Walz, W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.072 · Cited by 27
Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells
Vay, S. U., Blaschke, S. J., Klein, R. M., Fink, G. R., Schroeter, M., & Rueger, M. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23686 · Cited by 26
Karadimas, S. K., Gialeli, C., Klironomos, G., Tzanakakis, G. N., Panagiotopoulos, E. C., Karamanos, N. K., & Gatzounis, G. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790820598 · Cited by 29
UBE3A regulates the transcription of IRF, an antiviral immunity
Furumai, R., Tamada, K., Liu, X., & Takumi, T. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz019 · Cited by 26
Li, X., Hu, B., Xiaoyan, G., Wang, Z., Zhou, Y., Sun, H., Zhang, X., Li, Y., Huang, X., Zhao, Y., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02774-1 · Cited by 25
Treatment of children and adolescents with multiple sclerosis
Banwell, B. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.3.391 · Cited by 26
Further understanding of the immunopathology of multiple sclerosis: impact on future treatments
Bhise, V. V., & Dhib-Jalbut, S. S. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1191351 · Cited by 28
Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
Tan, J., Jiang, S., Tan, L., Shi, H., Yang, L., Sun, Y., & Wang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649026 · Cited by 28
Oudega, M., Bradbury, E. J., & Ramer, M. S. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52137-8.00038-3 · Cited by 25
Liu, B., Kim, E. H., Meggo, A., Gandhi, S., Luo, H., Kallakuri, S., Xu, Y. P., & Zhang, J. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa52dc · Cited by 25
Shi, W., Wang, Z., Pu, J., Wang, R., Guo, Z., Liu, C., Sun, J., Gao, L., & Zhou, R. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0356-2_12 · Cited by 25
Worlitzer, M. M. A., Viel, T., Jacobs, A. H., & Schwamborn, J. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12269 · Cited by 24
The Susceptibility Pathogenesis of Moyamoya Disease
Hu, J., Luo, J. D., & Chen, Q. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.01.083 · Cited by 24
Goossens, J., & Hachimi-Idrissi, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140424233036 · Cited by 24
Ganguly, K., Adhikary, K., Acharjee, A., Acharjee, P., Trigun, S. K., Mutlaq, A. S., Ashique, S., Yasmin, S., Alshahrani, A. M., & Ansari, M. Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135967 · Cited by 23
He, K.-L., Yu, X., Xia, L., Xie, Y., Qi, E., Wan, L., Hua, X., & Jing, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1526786 · Cited by 25
Cieślik, M., Pyszko, J., & Strosznajder, J. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.016 · Cited by 23
Schwartz, R. L., Wipfli, H. L., & Samet, J. M. (2011) · PubMed Central · Cited by 22
Ahmad, M., Zakaria, A., & Almutairi, K. M. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.04.003 · Cited by 22
Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage
Liu, Y., Mu, Y., Li, Z., Yong, V. W., & Xue, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.986469 · Cited by 22
Repurposing of pexidartinib for microglia depletion and renewal
Weyer, M.-P., Strehle, J., Schäfer, M. K. E., & Tegeder, I. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108565 · Cited by 23
Ruggieri, M., Pica, C., Lia, A., Zimatore, G. B., Modesto, M., Liddo, E. D., Specchio, L. M., Livrea, P., Trojano, M., & Avolio, C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.032 · Cited by 22
Goyal, M., McTaggart, R., Ospel, J. M., van der Lugt, A., Tymianski, M., Wiest, R., Lundberg, J., von Kummer, R., Hill, M. D., Luijten, S. P. R., et al. (2022) · Neuroradiology · doi:10.1007/s00234-022-03001-z · Cited by 21
Metalloproteinases and neurodegenerative diseases: pathophysiological and therapeutic perspectives
Rosenberg, G. A. (2015) · Metalloproteinases In Medicine · doi:10.2147/mnm.s68849 · Cited by 21
Tetracyclines and Neuromuscular Disorders
Orsucci, D., Mancuso, M., Filosto, M., & Siciliano, G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604498 · Cited by 21
Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice
Worlitzer, M. M. A., Bunk, E. C., Hemmer, K., & Schwamborn, J. C. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt124 · Cited by 21
Fan, X., Jiang, Y., Yu, Z., Yuan, J., Sun, X., Xiang, S., Lo, E. H., & Wang, X. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.007 · Cited by 21
Chen, X., Ma, L., Jiang, Y., Chen, S., Zhu, C., Liu, M., Ma, X., Zhu, D., Liu, Y., Peng, F., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.043 · Cited by 21
Metadata
- Authors
- Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Yong, V Wee
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 3
- Issue
- 12
- Pages
- 744-751
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2063885093
- Cited by
- 518
- References
- 64
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 20 · 2021: 19 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 19 · 2016: 17 · 2015: 28 · 2014: 33 · 2013: 32 · 2012: 35
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Multiple Sclerosis Society of Canada
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- minocycline, neuroprotection, stroke, multiple sclerosis, spinal cord injury, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, animal models of neurological disease, clinical trials
- MeSH terms
- Animals, Humans, Minocycline, Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review